Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nezam H Afdhal

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Gastroenterology|July 27, 2016
Effect of Registries and Cohort Studies on HCV TreatmentNezam H Afdhal, Lawrence Serfaty
Antiviral Therapy|June 3, 2010
Perspectives on fibrosis progression in hepatitis C: an à la carte approach to risk factors and staging of fibrosisThierry Poynard, Nezam H Afdhal
The American Journal of Medicine|February 3, 2009
Therapeutic strategies for chronic hepatitis B virus infection in 2008Asim Khokhar, Nezam H Afdhal
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 25, 2012
Biopsy no more; changing the screening and diagnostic algorithm for hepatitis CAlan Bonder, Nezam H Afdhal
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 19, 2010
Health care quality measurement in the care of patients with cirrhosisMichelle Lai, Nezam H Afdhal
Hepatology (Baltimore, Md.)|April 19, 2012
Clinical utility of interleukin-28B testing in patients with genotype 1Michelle Lai, Nezam H Afdhal
Gastroenterology Clinics of North America|August 25, 2004
Antiviral therapy for treatment naïve patients with hepatitis C virusSangik Oh, Nezam H Afdhal
The American Journal of Gastroenterology|December 6, 2011
Editorial: staging liver fibrosis in hepatitis C: a challenge for this decadeMichelle Lai, Nezam H Afdhal
The American Journal of Gastroenterology|June 8, 2004
Evaluation of liver fibrosis: a concise reviewNezam H Afdhal, David Nunes
Lancet (London, England)|March 11, 2008
Liver cirrhosisDetlef Schuppan, Nezam H Afdhal
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Gastroenterology|July 27, 2016
Effect of Registries and Cohort Studies on HCV TreatmentNezam H Afdhal, Lawrence Serfaty
Antiviral Therapy|June 3, 2010
Perspectives on fibrosis progression in hepatitis C: an à la carte approach to risk factors and staging of fibrosisThierry Poynard, Nezam H Afdhal
The American Journal of Medicine|February 3, 2009
Therapeutic strategies for chronic hepatitis B virus infection in 2008Asim Khokhar, Nezam H Afdhal
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 25, 2012
Biopsy no more; changing the screening and diagnostic algorithm for hepatitis CAlan Bonder, Nezam H Afdhal
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 19, 2010
Health care quality measurement in the care of patients with cirrhosisMichelle Lai, Nezam H Afdhal
Hepatology (Baltimore, Md.)|April 19, 2012
Clinical utility of interleukin-28B testing in patients with genotype 1Michelle Lai, Nezam H Afdhal
Gastroenterology Clinics of North America|August 25, 2004
Antiviral therapy for treatment naïve patients with hepatitis C virusSangik Oh, Nezam H Afdhal
The American Journal of Gastroenterology|December 6, 2011
Editorial: staging liver fibrosis in hepatitis C: a challenge for this decadeMichelle Lai, Nezam H Afdhal
The American Journal of Gastroenterology|June 8, 2004
Evaluation of liver fibrosis: a concise reviewNezam H Afdhal, David Nunes
Lancet (London, England)|March 11, 2008
Liver cirrhosisDetlef Schuppan, Nezam H Afdhal
Pageof 14